Skip to main content
Caplight Logo









Gibson Oncology, LLC

Gibson Oncology, LLC

Private
Miami, FloridaHealthcare & Life Scienceshttps://gibsononcology.com/

Last Round

VC Round

Jul 21, 2025

Total Funding Raised

$4.05M

Company Overview

Gibson Oncology, LLC is a biotechnology company that develops novel small molecule compounds for cancer therapy, focusing on dual inhibitors of topoisomerase I (TOP1) and the cMyc oncogene.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyoncologysmall-molecule therapeuticsdrug discoveryclinical trialsglioblastomacMyc inhibitortopoisomerase I inhibitordrug developmentbiotech startupcancer researchsolid tumorsblood-brain barrierprecision medicinedrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gibson Oncology, LLC Comparables

Compare Gibson Oncology, LLC with similar companies based on industry and business-model similarity.

Gibson Oncology, LLC comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Peel Therapeutics
81%
Hemispherian AS
79%
Global Cancer Technology, Inc.
79%

Gibson Oncology, LLC Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 21, 2025
SeedOct 17, 2024

Key People

Founding team and executive leadership

Clifford Solomon

Co-Founder And Chief Medical Officer

Founding Team

Randall Riggs

President CEO

Executive Team

Randy Riggs

President CEO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors grew 2001% MoM, from 79 to 1.7K.

Gibson Oncology, LLC Filings

Explore SEC and related filing metadata, where available.

Gibson Oncology, LLC filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Gibson Oncology, LLC's valuation, stock price, and market status.

Is Gibson Oncology, LLC a public or private company?

Gibson Oncology, LLC is a private company.

What is the current stock price of Gibson Oncology, LLC?

Gibson Oncology, LLC is a private company with no public stock price. No recent secondary market data is available.

How much is Gibson Oncology, LLC worth (valuation)?

Valuation information for Gibson Oncology, LLC is not publicly available.

Can I buy Gibson Oncology, LLC stock?

Gibson Oncology, LLC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Gibson Oncology, LLC's last funding round?

Gibson Oncology, LLC's most recent funding round was VC Round on July 21, 2025.

Who are the main investors in Gibson Oncology, LLC?

Investor information for Gibson Oncology, LLC is not publicly disclosed.

Will Gibson Oncology, LLC IPO soon?

No public IPO plans have been announced for Gibson Oncology, LLC.

How can I track Gibson Oncology, LLC secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gibson Oncology, LLC's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMiami, Florida
Employee Range5
Year Founded2018
Last FundingJul 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?